SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
4451Almost all deals of this nature are structured in such a way, but determining faDr. Voodoo-4/25/2008
4450The intro para dated 1996 speaks of ISIS being the next microsoft. Keep the faittom pope-4/25/2008
4449i've been in and out of isis since 96 and lucky enough to miss most of the tbob zagorin-4/25/2008
4448Well my track record on this one isn't too good. I owned it in 1996 for aboLJM-4/25/2008
4447Based on everything I've read here today, why not, indeed. Maybe a few sharetom pope-4/25/2008
4446Seemed like a good day to increase my ISIS 25 percent. Why not? ;-) If it goeLJM-4/25/2008
4445UPDATE 2-Isis to delay cholesterol drug data; shares drop Fri Apr 25, 2008 2:43pbob zagorin-4/25/2008
4444Piper Jaffray Tells Clients To Buy ISIS Pharma (ISIS) On Today's Weakness Abob zagorin-4/25/2008
4443yes i think some renegotiation is probable as in timetables / milestones and sombob zagorin-4/25/2008
4442<i>"Executives didn't say whether the regulatory clarity would afLJM-4/25/2008
4441FDA Delays Hit Genzyme, Isis JV Deal Elizabeth Trotta 04/25/08 - 12:31 PM EDT Gbob zagorin-4/25/2008
4440Looks like an overreaction to me. The news that the cholesterol drug might not Art Bechhoefer-4/25/2008
4439here's how a very knowlegdable poster put it on the IV thread and i agree 10bob zagorin-4/25/2008
4438i had sold 1/3 of position at 16. i bought back 1/2 of that today under 12.50. dbob zagorin-4/25/2008
4437Took about 30 minutes to get to 4 times normal daily volume... ISIS-Q Volume eIan@SI-4/25/2008
4436Are you buying back what you recently sold at the current price of 12.50,or do ymanny t-4/25/2008
4435>>FDA Provides Clarity to Isis Regarding the Development Path for Mipomerstuck-4/25/2008
4434proxy and annual report for isis.. Proxy Statement ISIS PHARMACEUTICALS, INC. Pbob zagorin-4/24/2008
4433posting another long wachovia detail on the isis diabetes trial which was the subob zagorin-4/23/2008
4432more from IV board.. Lengthy Wachovia comments re Mipomersen Plus comments by Gbob zagorin-4/23/2008
4431from IV board.. FH Trails and FDA + Genzyme Partnership per WACHOVIA HERE IS A bob zagorin-4/23/2008
4430April 21, 2008, 12:40 pm Merck Searches for Goldilocks Biotech Posted by Scott Hbob zagorin-4/23/2008
4429thanks for the input...here's another take from england on the GSK deal.. Rbob zagorin-4/19/2008
4428Bob, When it comes to biotech, Leerink Swann employs some very bright medical pIan@SI-4/18/2008
4427Regarding the 20 million short that is likely right on. For the first time in aMJ-4/18/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News